Botanical species · safety record

Chaenomeles speciosa

The EFSA Compendium of Botanicals holds 8 constituent measurements and 2 adverse-effect records for Chaenomeles speciosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chaenomeles speciosa (Sweet) Nakai

8Constituent measurements
2Safety records
1Cited sources
128Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 128 licensed products naming Chaenomeles speciosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Chaenomeles speciosa fruit
  • Dried nearly ripe fruit
  • Dried ripe fruit
  • Fruit
  • Nearly ripe fruit
  • Ripe fruit(s)

What the records describe

Constituents measured

  • Chlorogenic acid2
  • Gallic acid2
  • P-coumaric acid2
  • Saponins2

Plant parts

  • Fruit unspecified10

Preparations

  • Solvent extraction10

Effect types

  • Digestive2

Target tissues

  • Digestive: pancreas2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Chlorogenic acidFruit unspecifiedSolvent extraction≤ 236.08 Microgram/gramUV/VIS spectroscopy (photometry)Resolve DOI
Chlorogenic acidFruit unspecifiedSolvent extraction≥ 172.19 Microgram/gramUV/VIS spectroscopy (photometry)Resolve DOI
Gallic acidFruit unspecifiedSolvent extraction≥ 17.37 Microgram/gramUV/VIS spectroscopy (photometry)Resolve DOI
Gallic acidFruit unspecifiedSolvent extraction≤ 99.75 Microgram/gramUV/VIS spectroscopy (photometry)Resolve DOI
P-coumaric acidFruit unspecifiedSolvent extraction≤ 124.76 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
P-coumaric acidFruit unspecifiedSolvent extraction≥ 16.93 Microgram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
SaponinsFruit unspecifiedSolvent extraction≥ 44.13 Milligram-equivalent/gramUV/VIS spectroscopy (photometry)Resolve DOI
SaponinsFruit unspecifiedSolvent extraction≤ 60.61 Milligram-equivalent/gramUV/VIS spectroscopy (photometry)Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveDigestive: pancreasFruit unspecifiedSolvent extractionIn vitroResolve DOI
DigestiveDigestive: pancreasFruit unspecifiedSolvent extractionIn vitroResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Miao, Jing., Zhao, Chengcheng., Li, Xia., Chen, Xuetao., Mao, Xinhui., Huang, Hanhan., Wang, Tingting., Gao, Wenyuan. Chemical Composition and Bioactivities of Two Common Chaenomeles Fruits in China: Chaenomeles speciosa and Chaenomeles sinensis . Journal of food science, 2016, vol. 81, no. 8, p. H2049-H2058. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue